LU85870A1 - Nouvelles compositions pharmaceutiques antibacteriennes et antiprotozoaires et procede pour leur preparation - Google Patents
Nouvelles compositions pharmaceutiques antibacteriennes et antiprotozoaires et procede pour leur preparation Download PDFInfo
- Publication number
- LU85870A1 LU85870A1 LU85870A LU85870A LU85870A1 LU 85870 A1 LU85870 A1 LU 85870A1 LU 85870 A LU85870 A LU 85870A LU 85870 A LU85870 A LU 85870A LU 85870 A1 LU85870 A1 LU 85870A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- acid
- reindeer
- bow
- gastrointestinal
- organic acid
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 238000000034 method Methods 0.000 title description 2
- 230000000842 anti-protozoal effect Effects 0.000 title 1
- 239000003904 antiprotozoal agent Substances 0.000 title 1
- 239000002253 acid Substances 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 4
- 230000002195 synergetic effect Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 230000000241 respiratory effect Effects 0.000 claims description 2
- 230000002496 gastric effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 241000282941 Rangifer tarandus Species 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 241000588748 Klebsiella Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- UURAUHCOJAIIRQ-QGLSALSOSA-N tiamulin Chemical compound CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 UURAUHCOJAIIRQ-QGLSALSOSA-N 0.000 description 2
- 229960004885 tiamulin Drugs 0.000 description 2
- JAJIPIAHCFBEPI-UHFFFAOYSA-N 9,10-dioxoanthracene-1-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)O JAJIPIAHCFBEPI-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 101100226912 Mus musculus Fcsk gene Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU841681A HU192982B (en) | 1984-04-28 | 1984-04-28 | Process for producing synergetic pharmaceutical compositions containing thiamulin and antibacterial and antiprotozoal organic acids |
| HU168184 | 1984-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU85870A1 true LU85870A1 (fr) | 1986-11-05 |
Family
ID=10955659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU85870A LU85870A1 (fr) | 1984-04-28 | 1985-04-26 | Nouvelles compositions pharmaceutiques antibacteriennes et antiprotozoaires et procede pour leur preparation |
Country Status (11)
| Country | Link |
|---|---|
| AT (1) | AT388669B (de) |
| BE (1) | BE902250A (de) |
| CH (1) | CH666407A5 (de) |
| DE (1) | DE3515185A1 (de) |
| ES (1) | ES8607333A1 (de) |
| GB (1) | GB2158353A (de) |
| HU (1) | HU192982B (de) |
| IT (1) | IT1200461B (de) |
| LU (1) | LU85870A1 (de) |
| NL (1) | NL8501061A (de) |
| SE (1) | SE8502038L (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1208279A (en) * | 1967-05-12 | 1970-10-14 | Ici Ltd | Veterinary compositions containing 4-hydroxy-1,8-naphthyridine derivatives |
| GB2027590A (en) * | 1978-08-14 | 1980-02-27 | Squibb & Sons Inc | Parenteral compositions containing tiamulin |
| CH642850A5 (it) * | 1978-10-20 | 1984-05-15 | Ausonia Farma Srl | Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi. |
| GB2072012B (en) * | 1980-03-14 | 1984-07-25 | Squibb & Sons Inc | Veterinary compositions containing pleuromutilin derivatives |
-
1984
- 1984-04-28 HU HU841681A patent/HU192982B/hu not_active IP Right Cessation
-
1985
- 1985-04-11 NL NL8501061A patent/NL8501061A/nl not_active Application Discontinuation
- 1985-04-22 BE BE1/011243A patent/BE902250A/fr not_active IP Right Cessation
- 1985-04-24 CH CH1749/85A patent/CH666407A5/de not_active IP Right Cessation
- 1985-04-24 AT AT0122985A patent/AT388669B/de not_active IP Right Cessation
- 1985-04-26 ES ES542610A patent/ES8607333A1/es not_active Expired
- 1985-04-26 DE DE19853515185 patent/DE3515185A1/de not_active Withdrawn
- 1985-04-26 GB GB08510673A patent/GB2158353A/en not_active Withdrawn
- 1985-04-26 LU LU85870A patent/LU85870A1/fr unknown
- 1985-04-26 SE SE8502038A patent/SE8502038L/xx not_active Application Discontinuation
- 1985-04-26 IT IT20515/85A patent/IT1200461B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| GB2158353A (en) | 1985-11-13 |
| BE902250A (fr) | 1985-10-22 |
| DE3515185A1 (de) | 1985-11-07 |
| NL8501061A (nl) | 1985-11-18 |
| IT1200461B (it) | 1989-01-18 |
| HUT37347A (en) | 1985-12-28 |
| CH666407A5 (de) | 1988-07-29 |
| SE8502038L (sv) | 1985-10-29 |
| ATA122985A (de) | 1989-01-15 |
| AT388669B (de) | 1989-08-10 |
| ES8607333A1 (es) | 1986-05-16 |
| IT8520515A0 (it) | 1985-04-26 |
| SE8502038D0 (sv) | 1985-04-26 |
| ES542610A0 (es) | 1986-05-16 |
| HU192982B (en) | 1987-08-28 |
| GB8510673D0 (en) | 1985-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11758933B2 (en) | High intensity sweeteners | |
| AU759388B2 (en) | Pharmaceutical compositions containing lipase inhibitors and chitosan | |
| US4775749A (en) | Inclusion compound of eicosapentaenoic of acid and food product containing the same | |
| CN102245190A (zh) | 抗微生物组合物 | |
| DE102005046237A1 (de) | Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen | |
| JPWO2011108059A1 (ja) | キサンチンオキシダーゼ阻害剤 | |
| EP1264548B1 (de) | Physiologisch aktive mittel enthaltend vicinale dithioglykole sowie deren verwendung in unterschiedlichen wirtschaftsbereichen | |
| CN105935364A (zh) | 用于预防或治疗非酒精性肝病的包含人参皂苷f2的组合物 | |
| LU85870A1 (fr) | Nouvelles compositions pharmaceutiques antibacteriennes et antiprotozoaires et procede pour leur preparation | |
| CN102164509A (zh) | 氨基酸降解臭味防止剂、含氨基酸的食品或饮料及降解臭味防止方法 | |
| LU85823A1 (fr) | Nouvelles combinaisons de medicaments ayant un effet synergique et procede pour les preparer | |
| KR100424660B1 (ko) | 비타민강화 바실러스 폴리퍼멘티쿠스(Bacillus polyfermenticus) KCCM 10104 함유 정장기능성 영양식품 조성물 | |
| KR101359668B1 (ko) | 돌나물 추출물을 포함하는 항균 조성물 | |
| TW201642895A (zh) | α－葡萄糖苷酶抑制劑 | |
| JP2020066610A (ja) | エストラジオール産生促進用医薬組成物及び食品組成物 | |
| WO2022215619A1 (ja) | Ｇｌｐ－１分泌促進用組成物 | |
| KR101429197B1 (ko) | 전호 추출물을 포함하는 항균 조성물 | |
| US3051572A (en) | Method of preparing flavored stabilized feeds | |
| KR101776696B1 (ko) | 항균 활성을 나타내는 이소소르비드 유도체 및 이를 유효성분으로 포함하는 항균용 조성물 | |
| JP7221936B2 (ja) | 臭い成分不活性化用組成物 | |
| WO2003074040A1 (en) | Compositions for ameliorating fecal properties | |
| JP2024180038A (ja) | 経口組成物 | |
| US4196200A (en) | Antibiotic BM123-dioctyl sulfosuccinate complexes | |
| DE102006035801A1 (de) | Flüssig-Formulierung auf Basis einer Guanidinoessigsäure-Komponente | |
| KR20190014873A (ko) | 참가시나무 열매 및 바나바 잎의 혼합 추출물을 유효성분으로 함유하는 항균용 조성물 |